Leadership Overview
Sanofi has 10 executives leading key functions including finance, marketing, and operations.
Driven by scientific innovation, Sanofi is dedicated to improving lives through the discovery, development, and delivery of medicines and vaccines across critical therapeutic areas, advancing sustainable healthcare solutions globally.
Driven by scientific innovation, Sanofi is dedicated to improving lives through the discovery, development, and delivery of medicines and vaccines across critical therapeutic areas, advancing sustainable healthcare solutions globally.
Leadership Roles at Sanofi
Alvaro de Castro - Chief Financial Officer
Alvaro de Castro, the Chief Financial Officer at Sanofi, directs global financial strategy and operations. De Castro oversees all aspects of financial planning, reporting, and capital allocation, ensuring fiscal discipline and driving profitable growth. This leadership role involves managing investment portfolios, optimizing resource deployment, and maintaining robust financial controls across the enterprise. By analyzing market trends and economic indicators, de Castro provides critical financial insights to guide strategic decision-making. The Chief Financial Officer's purview extends to treasury functions, risk management, and investor relations, fostering confidence and transparency with stakeholders. Alvaro de Castro's financial acumen is essential for Sanofi's mission to deliver innovative healthcare solutions worldwide.
Colleen Proctor - Chief Financial Officer (North America)
Colleen Proctor, the Chief Financial Officer (North America) at Sanofi, directs financial operations and strategy for the North American region. Proctor manages regional financial planning, budgeting, forecasting, and performance analysis, ensuring alignment with global financial objectives. This leadership position involves optimizing financial resources, driving revenue growth, and maintaining fiscal accountability across North American markets. By providing strategic financial guidance, the Chief Financial Officer (North America) supports the successful launch and commercialization of Sanofi's innovative medicines and vaccines. Colleen Proctor's financial leadership is crucial for expanding Sanofi's impact and accessibility within the vital North American healthcare landscape.

Amber Doss - Chief of Staff, Specialty Care
Amber Doss, the Chief of Staff, Specialty Care at Sanofi, provides strategic support and operational oversight for the Specialty Care division. Doss aligns departmental objectives with overarching company goals, facilitating cross-functional collaboration and driving key initiatives. This role involves managing critical projects, enhancing communication channels, and ensuring efficient execution of strategic plans within the specialty care portfolio. By streamlining processes and optimizing resource allocation, the Chief of Staff, Specialty Care enhances the division's ability to deliver innovative treatments. Amber Doss's operational expertise is vital for advancing Sanofi's commitment to addressing complex health conditions through specialized therapies.
Rahma Al-Badawy - Sanofi PSP Patient Educator At Ray Chief Revenue Officer
Rahma Al-Badawy, the Sanofi PSP Patient Educator At Ray Chief Revenue Officer at Sanofi, drives revenue generation and enhances patient engagement strategies. Al-Badawy focuses on optimizing commercial performance and expanding market reach for Sanofi's patient support programs. This role involves developing and executing revenue-generating initiatives, fostering strong relationships with healthcare providers, and ensuring patient access to critical therapies. By championing patient-centric approaches, the Chief Revenue Officer contributes to Sanofi's mission of improving lives through innovative healthcare solutions. Rahma Al-Badawy's commercial expertise is instrumental in maximizing the impact of Sanofi's therapeutic offerings and patient support services.
Fariha Younes - Head Chief Marketing Officer, Real-World Evidence Governance, Development Strategy & Excellence
Fariha Younes, the Head Chief Marketing Officer, Real-World Evidence Governance, Development Strategy & Excellence at Sanofi, leads critical marketing initiatives focused on real-world evidence and strategic development. Younes oversees the governance and implementation of marketing strategies that leverage real-world data to inform product development and commercialization. This multifaceted role involves ensuring marketing excellence, driving strategic planning, and enhancing the value proposition of Sanofi's therapeutic areas. By integrating real-world evidence into marketing frameworks, Fariha Younes supports Sanofi's commitment to scientific innovation and patient-focused solutions. The Chief Marketing Officer's strategic vision is key to communicating the impact of Sanofi's advancements.
Vishal Mehrotra - Global Manager, Lead Medical Information & Chief Marketing Officer
Vishal Mehrotra, the Global Manager, Lead Medical Information & Chief Marketing Officer at Sanofi, bridges medical information dissemination with strategic marketing efforts. Mehrotra ensures accurate and timely communication of medical information while driving marketing strategies that align with scientific advancements. This dual focus role involves managing global medical information services and developing marketing campaigns that effectively convey the value of Sanofi's innovations. By integrating medical insights into marketing plans, Vishal Mehrotra enhances the company's ability to reach healthcare professionals and patients with critical information. The Chief Marketing Officer's leadership ensures that Sanofi's scientific achievements are communicated with clarity and impact.
KwangYong Nam - Director, Em & S Operational Quality & Chief Marketing Officer, Management
KwangYong Nam, the Director, Em & S Operational Quality & Chief Marketing Officer, Management at Sanofi, integrates operational quality standards with strategic marketing management. Nam oversees initiatives that ensure high-quality operations while driving effective marketing strategies across management functions. This role is critical for maintaining product integrity and enhancing market presence through robust quality control and targeted marketing efforts. By focusing on operational excellence and strategic marketing, KwangYong Nam supports Sanofi's commitment to delivering safe and effective healthcare solutions. The Chief Marketing Officer's management approach ensures that quality and market impact are closely aligned.
Penny Thomas - Chief Marketing Officer & Quality Specialist
Penny Thomas, the Chief Marketing Officer & Quality Specialist at Sanofi, leads marketing initiatives while ensuring adherence to stringent quality standards. Thomas drives marketing strategies that emphasize product quality and patient safety, aligning commercial efforts with Sanofi's commitment to excellence. This role involves developing compelling marketing campaigns that communicate the value and reliability of Sanofi's medicines and vaccines. By integrating quality assurance into marketing practices, Penny Thomas reinforces Sanofi's reputation for delivering trusted healthcare solutions. The Chief Marketing Officer's dual focus ensures that market communications reflect the highest standards of product integrity.
Fernanda Araujo - Global Regulatory Strategy & Business Excellence Lead Chief of Staff (Regulatory Head's )
Fernanda Araujo, the Global Regulatory Strategy & Business Excellence Lead Chief of Staff (Regulatory Head's ) at Sanofi, spearheads global regulatory strategy and drives business excellence within regulatory affairs. Araujo ensures seamless coordination of regulatory submissions and compliance initiatives across international markets. This critical role involves optimizing business processes, enhancing operational efficiency, and aligning regulatory strategies with Sanofi's overarching mission to deliver innovative medicines. By fostering strong collaboration between regulatory teams and business units, Fernanda Araujo facilitates the timely approval and market access of Sanofi's life-changing therapies. The Chief of Staff's strategic leadership is vital for navigating complex global regulatory landscapes.
Jennifer Mueller - Chief of Staff, Rare Disease
Jennifer Mueller, the Chief of Staff, Rare Disease at Sanofi, provides strategic leadership and operational support for the Rare Disease division. Mueller aligns departmental objectives with the division's mission to develop and deliver treatments for rare conditions. This role involves managing key projects, enhancing cross-functional communication, and ensuring the efficient execution of strategic initiatives within the rare disease portfolio. By streamlining operations and fostering collaboration, Jennifer Mueller supports Sanofi's commitment to addressing unmet medical needs. The Chief of Staff's focus on operational effectiveness is crucial for advancing Sanofi's impact in rare disease therapies.
Explore Leadership Teams in Manufacturing
IFF Pharma Solutions develops high-quality pharmaceutical excipients and biopolymers that support advanced drug delivery and biomedical applications. The company focuses on providing reliable, performance-driven ingredients that help pharmaceutical manufacturers improve formulation efficiency, product stability, and patient outcomes. With strong expertise in quality, regulatory compliance, and innovation, IFF Pharma Solutions plays a key role in enabling safe and effective medicines worldwide.
Company Leadership CP


Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
PM
RB
RK
Grupo NC is a leading Brazilian pharmaceutical company with roots dating back to 2014 when it began as a small pharmacy in Santo André. Officially founded in 1964 with its first factory in São Bernardo do Campo, the company has grown to become one of the largest pharmaceutical industries in Brazil. Grupo NC operates with a dual business model serving both B2B and B2C markets, offering innovative healthcare solutions and pharmacy retail services. The company maintains a strong presence in South America, particularly Brazil, while also expanding into Asian markets. Grupo NC is committed to sustainable development, innovation in healthcare solutions, and excellence in all operational aspects. The company's core values emphasize continuous improvement, responsible innovation, and making a positive impact in the markets where they operate.
Company Leadership DM
ND
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership AH
YS
LC
AD